Scientists call for more drugs, vaccines for multidrug-resistant TB

05/18/2010 | Reuters

Spending on research and development of drugs and vaccines for multidrug-resistant strains of tuberculosis should be increased as MDR-TB starts to advance in some countries, scientists said. Additional vaccines, treatments and diagnostic tests could reduce the global incidence of TB by 94% by 2050, they said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN